Event format
Learning Journey
Login
We offer our registered users tailored information, free online courses and exclusive content.
Can't find your password?
Reset it here.
Reset it here.
16th practice teaching course in MS knowledge
16th practice teaching course in MS knowledge
- Neurology
- Multiple sclerosis
Monday, Nov 12 - Tuesday, Nov 13 2018
Barcelona, Spain
Registration status
Not applicable
To register for this event, contact
Meridiano Congress International
Event Manager: David H. Slangen
T +39 06 88595 250 - F +39 06 88595 234 - [email protected]
Target audiences
This programme is designed for neurologists working in the field of multiple sclerosis
who want to acquire up-to date information for improving their current practice.
Files
Overview
The field of Multiple Sclerosis is rapidly evolving year by year requiring continuous education on all main aspects of the disease from pathogenesis to treatment. The aim of this blended learning journey is to strengthen knowledge in the main clinical and therapeutic dynamics that characterize modern MS.
A multistep approach will be used, encompassing web-based and live activities. The live intervention has come to its 16th edition and will provide an overview of advancements in MS through the knowledge and experience of local and international speakers. All activities – in person and online – will involve the full interactivity of learners.
Learning objectives
By attending this live intervention, participants will be able to:
- Describe immunopathogenesis of MS considering recent discoveries
- Apply new diagnostic criteria for MS
- Explain how to specific clinical challenges in MS (i.e. pregnancy, paediatric MS)
- Illustrate new treatment targets in MS
Scientific programme
Monday, 12 November 2018
SESSION I What is MS
Susanna Otero
L1: Epidemiology of MS
Tobias Derfuss
L2: Immunopathogenesis of MS
C. Stadelmann-Nessler
L3: Pathology of MS and other demyelinating disorders
Manuel Comabella
L4: Genetics of MS
Mar Tintorè
L6: Diagnostic criteria: what changes in practice
SESSION II Diagnosis and differential diagnosis
Jaume Sastre Garriga
L5: The clinical work up of patients suspected of having MS
Mar Tintorè
L6: Diagnostic criteria: what changes in practice
Alex Rovira
L7: Imaging in MS: the value of multimodal approach
Letizia Leocani
L8: Neurophysiology in MS: diagnostic and prognostic use
SESSION III Clinical challenges
Susanna Otero
L9: Impact of hormonal factors on MS risk and prognosis
Mar Tintorè
L10: Pediatric and Juvenile MS
Alan Thompson
L11: Primary Progressive MS
Georgina Arrambide
L12: Neuromyelitis Optica - NMO - and anti MOG disease
Tuesday, 13 November 2018
SESSION IV How to manage MS
Oscár Fernandez
L13: Overview of MS treatments and treatment algorithms
Oscár Fernandez
L14: New treatment targets and clinical trial results
SESSION V Prognosis
Jaume Sastre Garriga
L15: Prognostic factors at MS diagnosis
Jordi Rìo
L16: Prognostic factors during treatment
Herena Eixarch
SS1: Snapshot #1 on gene therapy in MS
Nicolàs Fissolo
SS2: Snapshot #2 on DNA vaccines in MS
E. Roger Meza
L17: Overview on symptomatic therapy and rehabilitation
Carme Santoyo
SS3: Symptomatic Therapy Snapshot #3 on gait rehabilitation
Marta Renom Guiteras
SS4: Symptomatic Therapy Snapshot #4 on Management of dysphagia
CME provider
EXCEMED - Excellence in Medical Education
Chair(s)
Xavier Montalban
Vall d’Hebron University Hospital
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Barcelona, Spain
St. Michael’s Hospital
Division of Neurology
University of Toronto
Toronto, Canada
Jaume Sastre Garriga
Unit of Clinical Neuroimmunology
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Speakers
Georgina Arrambide
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Manuel Comabella
Multiple Sclerosis Center of Catalonia Unit of Clinical Neuroimmunology
Vall d’Hebron University Hospital
Barcelona, Spain
Tobias Derfuss
Department of Neurology
University of Basel
Basel, Switzerland
Herena Eixarch
Unit of Neurorehabilitation
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Oscár Fernandez
Department of Neurology
Hospital Regional Universitario Carlos Haya
Malaga, Spain
Nicolàs Fissolo
Unit of Clinical Neuroimmunology
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Spain
Letizia Leocani
Institute of Experimental Neurology
University Vita-Salute IRCCS
Milan, Italy
E. Roger Meza
Department of Epidemiology
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain
Xavier Montalban
Vall d’Hebron University Hospital
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Barcelona, Spain
St. Michael’s Hospital
Division of Neurology
University of Toronto
Toronto, Canada
Susanna Otero
Department of Epidemiology
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Lluis Ramió i Torrentá
Department of Neurology
Multiple Sclerosis Unit
Dr. Josep Trueta Hospital
Girona, Spain
Marta Renom Guiteras
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain
Jordi Rìo
Unit of Clinical Neuroimmunology
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Alex Rovira
Department of Radiology
Unit of Magnetic Resonance
Vall d’Hebron University Hospital
Barcelona, Spain
Carme Santoyo
Unit of Neurorehabilitation
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Jaume Sastre Garriga
Unit of Clinical Neuroimmunology
Multiple Sclerosis Center of Catalonia
Vall d’Hebron University Hospital
Barcelona, Spain
Christine Stadelmann-Nessler
Institute for Neuropathology
University Medical Center Göttingen
Göttingen, Germany
Alan Thompson
Department of Brain Repair and Rehabilitation
Institute of Neurology
National Hospital for Neurology and Neurosurgery
Queen Square
London, United Kingdom
Mar Tintorè
Neurology-Neuroimmunology Department
Multiple Sclerosis Centre of Catalonia (Cemcat)
Vall d’Hebron University Hospital
Barcelona, Spain